News

The companies are working to smoothly shift activities and make sure the continuous availability of the product in approved countries. Merck Research Laboratories atherosclerosis and cardiovascular research senior

Under the agreement, Philip Morris will use Medicago’s technologies and VLPs for developing, manufacturing Medicago’s pandemic and seasonal influenza vaccines in china. The terms of Philip Morris’ deal

AEZS-130 patent came into effect from 19 September 2012 and will be valid till 19 February 2027. Aeterna Zentaris president and CEO Juergen Engel said the patent in

Pervenio Lung RS is also expected to meet prognostic information needed to guide preventative treatment and improve disease management. The test consists of a quantitative PCR (polymerase chain

The FDA has not granted orphan drug exclusivity to Gralise, even though the product was approved for orphan drug designation in November 2010 for the management of PHN

The patent will extend coverage period by at least until 2031, which is nine years longer than the granted patent coverage earlier to the company. The patent applications

The milestone was triggered as a result of the transition of an oncology programme into pre-clinical profiling. Evotec chief operating officer Dr Mario Polywka said under the alliance

Under the terms of the agreement, Atreca will apply the technology to particular infectious diseases and share the results with the foundation for use in the discovery and

Raspberry Keytone is designed for increasing the levels of protein hormone, adiponectin, which modulates glucose regulation and fatty acidcatabolism processes. Past research into adiponectin has shown that adiponectin